Discounted Cash Flow (DCF) Analysis Levered
P3 Health Partners Inc. (PIII)
$4.69
+0.07 (+1.52%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
| Revenue | 145.89 | 485.54 | 1,615.89 | 5,377.73 | 17,897.19 | 59,562.27 | 198,224.56 |
|---|---|---|---|---|---|---|---|
| Revenue (%) | |||||||
| Operating Cash Flow | -28.29 | -24.60 | -197.57 | -657.53 | -2,188.28 | -7,282.66 | -24,236.85 |
| Operating Cash Flow (%) | |||||||
| Capital Expenditure | -1.45 | -2.93 | -12.91 | -42.97 | -142.99 | -475.87 | -1,583.71 |
| Capital Expenditure (%) | |||||||
| Free Cash Flow | -29.74 | -27.52 | -210.48 | -700.50 | -2,331.27 | -7,758.53 | -25,820.57 |
Weighted Average Cost Of Capital
| Share price | $ 4.69 |
|---|---|
| Beta | 0.000 |
| Diluted Shares Outstanding | 68.16 |
| Cost of Debt | |
| Tax Rate | 9.49 |
| After-tax Cost of Debt | -% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 3.748 |
| Total Debt | 49.11 |
| Total Equity | 319.67 |
| Total Capital | 368.78 |
| Debt Weighting | 13.32 |
| Equity Weighting | 86.68 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
| Revenue | 145.89 | 485.54 | 1,615.89 | 5,377.73 | 17,897.19 | 59,562.27 | 198,224.56 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.29 | -24.60 | -197.57 | -657.53 | -2,188.28 | -7,282.66 | -24,236.85 |
| Capital Expenditure | -1.45 | -2.93 | -12.91 | -42.97 | -142.99 | -475.87 | -1,583.71 |
| Free Cash Flow | -29.74 | -27.52 | -210.48 | -700.50 | -2,331.27 | -7,758.53 | -25,820.57 |
| WACC | |||||||
| PV LFCF | - | - | -2,331.27 | - | - | ||
| SUM PV LFCF | - |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | - |
| Free cash flow (t + 1) | -26,336.98 |
| Terminal Value | - |
| Present Value of Terminal Value | - |
Intrinsic Value
| Enterprise Value | - |
|---|---|
| Net Debt | 12.85 |
| Equity Value | - |
| Shares Outstanding | 68.16 |
| Equity Value Per Share | - |